Empowering Mass Spec for Biotech and Beyond
Company is active
Event Year: 2022
Company is active
Event Year: 2022
Andson Biotech is dedicated to enhancing mass spectrometry for the biotechnology and pharmaceutical sectors. The company provides solutions that enable pharmaceutical firms to accurately measure and analyze challenging-to-detect chemicals, which are crucial in the development and manufacturing of advanced therapies, including cell therapies and biologics. Andson Biotech's technologies facilitate rapid and precise chemical measurements, essential for drug development and quality control processes, performed routinely by drug companies.
Andson Biotech is dedicated to enhancing mass spectrometry for the biotechnology and pharmaceutical sectors. The company provides solutions that enable pharmaceutical firms to accurately measure and analyze challenging-to-detect chemicals, which are crucial in the development and manufacturing of advanced therapies, including cell therapies and biologics. Andson Biotech's technologies facilitate rapid and precise chemical measurements, essential for drug development and quality control processes, performed routinely by drug companies.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2022
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2022
Healthcare
Healthcare
Healthcare
Healthcare
Team size: 4
Hiring: Yes
Team size: 4
Hiring: Yes